Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 2Rhabdoid Tumor 2Medulloblastoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Wilms Tumor 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Spinal Cord Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nephroma, Mesoblastic 1Neoplasms, Germ Cell and Embryonal 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Liver Neoplasms 1Kidney Neoplasms 1Immunoblastic Lymphadenopathy 1Hepatoblastoma 1

Interventions

Cisplatin 8Carboplatin 8X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6Cyclophosphamide 6sodium thiosulfate 5Vincristine 5Nuclear Medicine Department, Hospital 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Doxorubicin 5Biopsy 5Melphalan 4Irinotecan 4Fluorouracil 4fludarabine 3Thiotepa 3Oxaliplatin 3Mesna 3Gemcitabine 3Filgrastim 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatoblastoma × etoposide phosphate × Gastrointestinal × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡